UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Compliance with National and International Guidelines in the Treatment of Nonmotor Symptoms in Late-Stage Parkinson’s Disease

Parkinson's disease, 2023-10, Vol.2023, p.1-11

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson's disease

Scientific reports, 2022-01, Vol.12 (1), p.526-526, Article 526

2022

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal prediction of falls and near falls frequencies in Parkinson’s disease: a prospective cohort study

Journal of neurology, 2021-03, Vol.268 (3), p.997-1005

2021

Link zum Volltext

Verfügbarkeit prüfen

Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID‐19 Experience

Movement disorders clinical practice (Hoboken, N.J.), 2020-05, Vol.7 (4), p.361-372

2020

Link zum Volltext

Verfügbarkeit prüfen

Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: Final 12-month, open-label results

Movement disorders, 2015-04, Vol.30 (4), p.500-509

2015

Link zum Volltext

Verfügbarkeit prüfen

Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease

Journal of neurology, 2012-08, Vol.259 (8), p.1639-1647

2012

Link zum Volltext

Verfügbarkeit prüfen

Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life

Movement disorders, 2009-07, Vol.24 (10), p.1468-1474

2009

Link zum Volltext

Verfügbarkeit prüfen

The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the nonmotor symptoms questionnaire

Movement disorders, 2010-04, Vol.25 (6), p.704-709

2010

Link zum Volltext

Verfügbarkeit prüfen

Caregiver Burden and Quality of Life in Late Stage Parkinson's Disease

Brain sciences, 2022-01, Vol.12 (1), p.111

2022

Link zum Volltext

Verfügbarkeit prüfen

The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study

Movement disorders, 2007-10, Vol.22 (13), p.1901-1911

2007

Link zum Volltext

Verfügbarkeit prüfen

High risk of developing dementia in Parkinson’s disease: a Swedish registry-based study

Scientific reports, 2022-10, Vol.12 (1), p.16759-16759, Article 16759

2022

Link zum Volltext

Verfügbarkeit prüfen

Pros and cons of apomorphine and l -dopa continuous infusion in advanced Parkinson's disease

Parkinsonism & related disorders, 2009-12, Vol.15, p.S97-S100

2009

Link zum Volltext

Verfügbarkeit prüfen

Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials

Movement disorders, 2016-04, Vol.31 (4), p.538-546

2016

Link zum Volltext

Verfügbarkeit prüfen

Effects of safinamide on pain in patients with fluctuating Parkinson's disease

Brain and behavior, 2021-10, Vol.11 (10), p.e2336-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

A systematic practice review: Providing palliative care for people with Parkinson’s disease and their caregivers

Palliative Medicine, 2024-01, Vol.38 (1), p.57-68

2024

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients

The AAPS journal, 2013-04, Vol.15 (2), p.316-323

2013

Link zum Volltext

Verfügbarkeit prüfen

Perspectives on Care for Late-Stage Parkinson’s Disease

Parkinson's disease, 2021, Vol.2021, p.9475026-11

2021

Link zum Volltext

Verfügbarkeit prüfen

Tumoral parkinsonism—Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatment

Brain and behavior, 2023-08, Vol.13 (8), p.e3151-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need

PloS one, 2013-02, Vol.8 (2), p.e57221

2013

Link zum Volltext

Verfügbarkeit prüfen

Quantitative assessment of non-motor fluctuations in Parkinson’s disease using the Non-Motor Symptoms Scale (NMSS)

Journal of Neural Transmission, 2015-12, Vol.122 (12), p.1673-1684

2015

Link zum Volltext

Verfügbarkeit prüfen

Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus

NPJ Parkinson's Disease, 2022-02, Vol.8 (1), p.17-17, Article 17

2022

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients

Movement disorders, 2007-08, Vol.22 (11), p.1623-1629

2007

Link zum Volltext

Verfügbarkeit prüfen

Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach

Current medical research and opinion, 2018-12, Vol.34 (12), p.2063-2073

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 210

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(202)
Mit Volltextzugriff
(193)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Compliance with National and International Guidelines in the Treatment of Nonmotor Symptoms in Late-Stage Parkinson’s Disease

Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson's disease

Longitudinal prediction of falls and near falls frequencies in Parkinson’s disease: a prospective cohort study

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID‐19 Experience

Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: Final 12-month, open-label results

Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease

Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life

The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the nonmotor symptoms questionnaire

Caregiver Burden and Quality of Life in Late Stage Parkinson's Disease

The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study

High risk of developing dementia in Parkinson’s disease: a Swedish registry-based study

Pros and cons of apomorphine and l -dopa continuous infusion in advanced Parkinson's disease

Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials

Effects of safinamide on pain in patients with fluctuating Parkinson's disease

A systematic practice review: Providing palliative care for people with Parkinson’s disease and their caregivers

Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients

Perspectives on Care for Late-Stage Parkinson’s Disease

Tumoral parkinsonism—Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatment

International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study

A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need

Quantitative assessment of non-motor fluctuations in Parkinson’s disease using the Non-Motor Symptoms Scale (NMSS)

Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus

Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients

Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach

Suchergebnisse filtern